The US regulator has reported a sharp rise in expected savings after completing its second round of Medicare drug price ...
The American medicines regulator has approved a reformulated version of ranitidine from USA-based VKT Pharma, restoring the ...
Chinese biotech companies are pivoting from "fast-follow" to "smart" first-in-class (FIC) innovation, a shift that is ...
India’s Sun Pharmaceutical Industries today announced the US Food and Drug Administration (FDA) approved an updated label for ...
Shares of Las Vegas, USA-based PharmaCyte Biotech rose 25% by close yesterday, after it announced the successful monetization ...
The US Food and Drug Administration approved AstraZeneca’s Imfinzi (durvalumab) with fluorouracil, leucovorin, oxaliplatin, ...
Chinese biotech Akeso (HKEX: 9926) has secured Breakthrough Therapy Designation for Idafang (ivonescimab) in triple-negative ...
The US Food and Drug Administration (FDA) has granted accelerated approval of Voyxact (sibeprenlimab-szsi) for the reduction ...
Neurizon has appointed Justine Conway, global head of business development at US animal-health group Elanco (NYSE: ELAN), as ...
In a show of rare bipartisan agreement in the US Congress, lawmakers raised concerns over how the 340B program is driving up ...
A biotechnology company developing oral macrocyclic-peptide therapies designed to combine small-molecule convenience with ...
Cantor Fitzgerald analysts have connected with Danish biotech Ascendis Pharma’s on the three-month Prescription Drug User Fee Act (PDUFA) extension of TransCon hGH) CNP (navepegritide) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback